NCT06594939 2026-05-01Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell LymphomaMedical College of WisconsinPhase 2 Not yet recruiting31 enrolled